IMV Inc. completes US$25M long-term debt facility

On December 18, 2021, IMV Inc. ("IMV") closed its US$25 million long-term debt facility led by Horizon Technology Finance Corporation. US$15 million of the facility was funded upon closing, and CAD$4.5 million of this amount will go towards paying off IMV's loan with the Nova Scotia government. IMV will have access to the remaining US$10 million once they have achieved a predetermined milestone. 

IMV is a biopharmaceutical company based in Dartmouth, Nova Scotia. It is focused on creating more effective immunotherapies for cancer and other diseases.

McCarthy Tétrault LLP advised IMV with a team led by Philippe Leclerc that included Valérie Trudeau (Business).